Form 4 for MRNA Moderna
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001127602-22-004602 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-11 | 2022-02-09 | MRNA | Andres Juan | See remarks | M - OptEx | $7.60 | +3,740 | 1,740 | New | +$28.4K |
| DM | 2022-02-11 | 2022-02-09+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $155.54 | -2,768 | 0 | -100% | -$430.5K |
| DM | 2022-02-11 | 2022-02-09 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -3,740 | 24.6K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | M | A | 2,000 | $14.22 | 2,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-10 | S | D | 768 | $158.89 | 972 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-09 | S | D | 2,000 | $154.26 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-09 | M | A | 1,740 | $0.00 | 1,740 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2022-02-09 | M | D | 1,740 | $0.00 | 5,223 | D | $0.00 · — to — | 1,740 Common Stock | (F5) 25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-02-09 | M | D | 2,000 | $0.00 | 24,629 | D | $14.22 · — to 2028-02-28 | 2,000 Common Stock | (F4) 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. |